Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

被引：4
|
作者：
Kamal, Mohamed A. [1 ]
Ganguly, Samit [1 ]
Kadambi, Ananth [2 ]
Smith, Patrick F. [2 ]
机构：
[1] Regeneron Pharmaceut, Tarrytown, NY 10591 USA
[2] Certara, Princeton, NJ 08540 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 03期
关键词：
D O I：
10.1002/cpt.3357
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：518 / 521
页数：4
相关论文
共 50 条
  • [31] Model-Informed Drug Development: Steps Toward Harmonized Guidance
    Marshall, Scott
    Ahamadi, Malidi
    Chien, Jenny
    Iwata, Daisuke
    Farkas, Pavel
    Filipe, Augusto
    Frey, Nicolas
    Greene, Erin
    Kawai, Norisuke
    Li, Jian
    Lippert, Jorg
    Tshinanu, Flora Musuamba
    Manolis, Efthymios
    Peterson, Mark C.
    Sarem, Sarem
    Shebley, Mohamad
    Tegenge, Million
    Tsai, Chia-Hsun
    Tu, Chien-Lung
    Otsubo, Yasuto
    Wei, Jiawei
    Zhang, Lucia
    Zhu, Hao
    Karlsson, Kristin E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (05) : 954 - 959
  • [32] Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives
    Marshall, Scott
    Madabushi, Rajanikanth
    Manolis, Efthymios
    Krudys, Kevin
    Staab, Alexander
    Dykstra, Kevin
    Visser, Sandra A. G.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (02): : 87 - 96
  • [33] Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development
    Susanto, Budi O.
    Wicha, Sebastian G.
    Hu, Yanmin
    Coates, Anthony R. M.
    Simonsson, Ulrika S. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 274 - 286
  • [34] Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of Iberdomide
    Caroline Sychterz
    Ping Chen
    Ajay Saxena
    Hongxia Lin
    Lu Chen
    Yan Li
    Lu Gaohua
    Yiming Cheng
    The AAPS Journal, 27 (4)
  • [35] Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future
    Wu, Yue-E
    Zheng, Yuan-Yuan
    Li, Qiu-Yue
    Yao, Bu-Fan
    Cao, Jing
    Liu, Hui-Xin
    Hao, Guo-Xiang
    van den Anker, John
    Zheng, Yi
    Zhao, Wei
    ADVANCED DRUG DELIVERY REVIEWS, 2024, 211
  • [36] Model-Informed Reverse and Forward Translation of Safety Risks in Drug Development
    Mettetal, Jerome T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (02) : 199 - 201
  • [37] Model-Informed drug development of gastroretentive release systems for sildenafil citrate
    de Souza, Fabio Pinheiro
    Zimmermann, Estevan Sonego
    Silva, Raizza Tafet Carminato
    Borges, Luiza Novaes
    Nova, Monica Villa
    Lima, Marli Miriam de Souza
    Diniz, Andrea
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 182 : 81 - 91
  • [38] Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations
    Zhang, Miao
    Yu, Zhiheng
    Liu, Huan
    Wang, Xu
    Li, Haiyan
    Yao, Xueting
    Liu, Dongyang
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (03) : 259 - 273
  • [39] Leveraging model-informed approaches for drug discovery and development in the cardiovascular space
    Dockendorf, Marissa F.
    Vargo, Ryan C.
    Gheyas, Ferdous
    Chain, Anne S. Y.
    Chatterjee, Manash S.
    Wenning, Larissa A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (03) : 355 - 364
  • [40] Leveraging model-informed approaches for drug discovery and development in the cardiovascular space
    Marissa F. Dockendorf
    Ryan C. Vargo
    Ferdous Gheyas
    Anne S. Y. Chain
    Manash S. Chatterjee
    Larissa A. Wenning
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 355 - 364
12345